XBIT
XBiotech Inc. NASDAQ$2.55
Mkt Cap $77.7M
52w Low $2.09
30.3% of range
52w High $3.61
50d MA $2.38
200d MA $2.58
P/E (TTM)
-1.7x
EV/EBITDA
1.0x
P/B
0.6x
Debt/Equity
0.0x
ROE
-32.5%
P/FCF
-1.8x
RSI (14)
—
ATR (14)
—
Beta
0.83
50d MA
$2.38
200d MA
$2.58
Avg Volume
37.1K
About
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | AMC | 0.04 | -0.88 | -2300.0% | 2.31 | +0.4% | -0.4% | -2.6% | -2.6% | +1.7% | +3.5% | — |
| Nov 12, 2025 | AMC | — | -0.20 | — | 2.77 | -0.4% | -4.3% | -4.7% | -10.8% | -15.2% | -22.0% | — |
| Aug 13, 2025 | AMC | — | -0.06 | — | 3.14 | -1.0% | +3.2% | +0.3% | +1.9% | +2.2% | +2.5% | — |
| May 14, 2025 | AMC | — | -0.36 | — | 2.88 | -0.3% | +3.5% | +5.6% | +6.6% | +3.1% | -0.3% | — |
| Mar 18, 2025 | AMC | — | -0.34 | — | 3.42 | +0.9% | +1.8% | +0.9% | +0.6% | +1.2% | -3.5% | — |
| Nov 13, 2024 | AMC | — | -0.16 | — | 7.10 | +1.0% | -1.8% | -6.2% | -6.1% | -6.1% | -8.6% | — |
| Aug 12, 2024 | AMC | — | -0.43 | — | 6.54 | +0.6% | -1.7% | -4.6% | -2.6% | -7.2% | -1.5% | — |
| May 10, 2024 | AMC | — | -0.33 | — | 8.31 | +0.0% | +3.0% | +6.0% | +3.4% | +3.2% | +1.4% | — |
| Mar 15, 2024 | AMC | — | -0.16 | — | 5.91 | +0.5% | +12.2% | +20.3% | +21.2% | +22.7% | +26.9% | — |
| Nov 9, 2023 | AMC | — | -0.24 | — | 3.83 | +2.3% | +2.9% | +2.6% | -0.5% | -0.8% | -3.4% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 7 | Piper Sandler | Maintains | Overweight → Overweight | — | $12.89 | $12.99 | +0.8% | -5.1% | -1.2% | +3.3% | +4.4% | +9.5% |
| Dec 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $18.89 | $20.00 | +5.8% | +2.6% | +4.6% | +5.1% | +3.1% | +5.3% |
| Dec 11 | PiperJaffray | Maintains | Overweight → Overweight | — | $18.89 | $20.00 | +5.8% | +2.6% | +4.6% | +5.1% | +3.1% | +5.3% |
| Jun 14 | Piper Jaffray | Maintains | Overweight → Overweight | — | $6.99 | $7.24 | +3.6% | +2.3% | +4.1% | +9.6% | +5.9% | +5.0% |
| Jun 14 | Piper Sandler | Maintains | Overweight → Overweight | — | $6.99 | $7.24 | +3.6% | +2.3% | +4.1% | +9.6% | +5.9% | +5.0% |
Data updated apr 24, 2026 11:42am
· Source: massive.com